Skip to content

Clinical effects of TCM Combined Therapy on Insulin Resistance in the treatment of Polycystic Ovarian Syndrome with Spleen Deficiency and Phlegm-dampness

Clinical effects of TCM Combined Therapy on Insulin Resistance in the treatment of Polycystic Ovarian Syndrome with Spleen Deficiency and Phlegm-dampness

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023340
Enrollment
Unknown
Registered
2019-05-23
Start date
2019-05-27
Completion date
Unknown
Last updated
2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovarian Syndrome

Interventions

Sponsors

Beijing University of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Female, aged 18 to 35 years; (2) Diagnosed with PCOS and insulin resistance; (3) TCM syndrome differentiation is spleen deficiency, phlegm and dampness syndrome; (4) BMI 23-32 kg/m2; (5) No birth planning in the future three months; (6) Being able to follow the plan for treatment, examination and follow-up; (7) Fully understand and voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Abnormal liver and kidney functions; (2) Alcoholism, malignant tumors, epilepsy or mental disorders; (3) The courses of type 2 diabetes mellitus and hypertension are more than 5 years; type 1 diabetes mellitus; (4) Coronary heart disease, severe arrhythmia, cardiopulmonary insufficiency or having undergone cardiac stenting; (5) With a pacemaker, hearing aid or other electronic or metal components; (6) Infectious diseases and severe skin lesions; (7) Pregnant or lactating women; (8) Having had weight-loss surgery or gastrointestinal surgery; (9) Various types of operations within half a year ; (10)Unable to cooperate with the research caused by other diseases or reasons.

Design outcomes

Primary

MeasureTime frame
HOMA-IR;OGTT;

Secondary

MeasureTime frame
B-ultrasound;Menstruation;Medical examination;Sex hormones;Serum lipids;

Countries

China

Contacts

Public ContactTao Lu

Beijing University of Chinese Medicine

taolu@bucm.edu.cn+86 13718417129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026